In: Neurochemical Research, 2015, vol. 40, no. 12, p. 2639-2646
|
In: Plos pathogens, 2018, vol. 14, no. 10, p. e1007335
Antibodies to the prion protein, PrP, represent a promising therapeutic approach against prion diseases but the neurotoxicity of certain anti-PrP antibodies has caused concern. Here we describe scPOM-bi, a bispecific antibody designed to function as a molecular prion tweezer. scPOM-bi combines the complementarity-determining regions of the neurotoxic antibody POM1 and the neuroprotective...
|
In: Journal of Neurology, 2005, vol. 252, no. 3, p. 338-342
|
In: Journal of Molecular Neuroscience, 2004, vol. 23, no. 1-2, p. 3-11
|
In: Journal of Neurology, 2008, vol. 255, no. 10, p. 1464-1472
|
In: Human Molecular Genetics, 2000, vol. 9, no. 12, p. 1853-1864
|
In: Human Molecular Genetics, 1995, vol. 4, no. 3, p. 359-366
|
In: Brain, 1999, vol. 122, no. 8, p. 1563-1577
|
In: The Journal of Infectious Diseases, 2009, vol. 199, no. 2, p. 243-252
|
In: Human Molecular Genetics, 2005, vol. 14, no. 15, p. 2241-2246
|